Reported 9 months ago
Walgreens Boots Alliance Inc. reported third-quarter fiscal year 2024 sales of $36.35 billion, with adjusted operating income decreasing by 36.3%. Adjusted earnings per share were $0.63, missing consensus estimates. The U.S. Retail Pharmacy segment's sales increased by 2.3%, driven by pharmacy sales, while retail sales declined. The company lowered its fiscal year 2024 adjusted EPS guidance due to industry trends and a challenging consumer environment, causing the stock price to drop by 15.40% during premarket trading.
Source: YAHOO